| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2159779 | Radiotherapy and Oncology | 2009 | 7 Pages |
Abstract
BDFS is similar between RP and IMRT for patients with a favorable or intermediate prognosis. Patients with a poor prognosis display higher BDFS when treated with IMRT to ⩾72 Gy plus hormonal therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ayal A. Aizer, James B. Yu, John W. Colberg, Anne M. McKeon, Roy H. Decker, Richard E. Peschel,